Papers: 21 Jan 2013 - 28 Jan 2013 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Editors' Pick Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship? Borisow N, Meyer T, Paul F BMJ Case Rep. 2013; 2013. Epub 1969 Dec 31. PMID: 23349176. Abstract Editors' Pick Development of a Standardized MRI Scoring Tool for CNS Demyelination In Children. Verhey LH, Branson HM, Laughlin S, Shroff MM, Benseler SM, Feldman BM, Streiner DL, Sled JG, Banwell B AJNR Am J Neuroradiol. 2013 Jan 24. Epub 1969 Dec 31. PMID: 23348761. Abstract Editors' Pick Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis - Association and Prediction. Løken-Amsrud KI, Myhr K-M, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, et al. PLoS One. 2013; 8(1):e54417. Epub 2013 Jan 22. PMID: 23349882. Abstract Exposure to anaesthetic agents does not affect multiple sclerosis risk. Hedström A, Hillert J, Olsson T, Alfredsson L Eur J Neurol. 2013 Jan 24. PMID: 23347426. Abstract Exercise barriers and preferences among women and men with multiple sclerosis. Asano M, Duquette P, Andersen R, Lapierre Y, Mayo NE Disabil Rehabil. 2013 Mar; 35(5):353-61. PMID: 23347461. Abstract MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentary. Selchen D, Bhan V, Blevins G, Devonshire V, Duquette P, Grand'Maison F, Kremenchutzky M, Lapierre Y, Li D, von Riedemann S J, et al. Neurology. 2012 Dec 4; 79(23 Suppl 2):S1-15. PMID: 23212280. Abstract Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis. Baumstarck K, Pelletier J, Butzkueven H, Fernández O, Flachenecker P, Idiman E, Stecchi S, Boucekine M, Auquier P, for the MusiQoL study group Eur J Neurol. 2013 Jan 24. PMID: 23347258. Abstract Quality of life in patients with multiple sclerosis in Republic of Srpska. Tadić D, Dajić V Med Glas Ljek komore Zenicko-doboj kantona. 2013 Feb; 10(1):113-9. PMID: 23348172. Abstract Spatial tuning function of pattern visual evoked potentials in multiple sclerosis patients without optic neuritis history. Taş A, Gundogan F C, Akgun H, Erdem U, Sobaci G Med Glas Ljek komore Zenicko-doboj kantona. 2013 Feb; 10(1):99-105. PMID: 23348170. Abstract Functional Homotopic Changes in Multiple Sclerosis with Resting-State Functional MR Imaging. Zhou Y, Milham M, Zuo X-N, Kelly C, Jaggi H, Herbert J, Grossman RI, Ge Y AJNR Am J Neuroradiol. 2013 Jan 24. PMID: 23348760. Abstract Visualizing iron in multiple sclerosis. Bagnato F, Hametner S, Welch E B Magn Reson Imaging. 2013 Jan 21. PMID: 23347601. Abstract The therapeutic value of yoga in neurological disorders. Mishra SK, Singh P, Bunch SJ, Zhang R Ann Indian Acad Neurol. 2012 Oct; 15(4):247-54. PMID: 23349587. Abstract A cluster randomised controlled trial on the efficacy of client-centred occupational therapy in multiple sclerosis: good process, poor outcome. Eyssen ICJM, Steultjens MPM, de Groot V, Steultjens EMJ, Knol DL, Polman CH, Dekker J Disabil Rehabil. 2013 Jan 24. PMID: 23343363. Abstract Documenting outdoor activity and travel behaviour in persons with neurological conditions using travel diaries and GPS tracking technology: a pilot study in multiple sclerosis. Neven A, Janssens D, Alders G, Wets G, Van Wijmeersch B, Feys P Disabil Rehabil. 2013 Jan 24. PMID: 23343357. Abstract Your client has multiple sclerosis: understanding the challenge. Orthop Nurs. 2013 Jan; 32(1):51-2. PMID: 23344492. Abstract Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology. Comi G, Battaglia M A, Bertolotto A, Del Sette M, Ghezzi A, Malferrari G, Salvetti M, Sormani M P, Tesio L, Stolz E, et al. Neurol Sci. 2013 Jan 24. PMID: 23344741. Abstract Oligodendrocyte N-Methyl-D-aspartate Receptor Signaling: Insights into Its Functions. Cao N, Yao Z-X Mol Neurobiol. 2013 Jan 24. PMID: 23345133. Abstract Your client has multiple sclerosis: understanding the challenge. Turkoski B Orthop Nurs. 2013 Jan; 32(1):45-50. PMID: 23344490. Abstract Female Gender and Reproductive Factors Affecting Risk, Relapses and Progression in Multiple Sclerosis. D'hooghe M, D'Hooghe T, De Keyser J Gynecol Obstet Invest. 2013 Jan 18. PMID: 23343711. Abstract Eriocalyxin B ameliorates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells. Lu Y, Chen B, Song J-H, Zhen T, Wang B-Y, Li X, Liu P, Yang X, Zhang Q-L, Xi X-D, et al. Proc Natl Acad Sci U S A. 2013 Jan 23. PMID: 23345445. Abstract Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation. Lossius A, Johansen JN, Torkildsen Ø, Vartdal F, Holmøy T Viruses. 2012 Dec; 4(12):3701-30. PMID: 23342374. Abstract Activated Invariant NKT Cells Control Central Nervous System Autoimmunity in a Mechanism That Involves Myeloid-Derived Suppressor Cells. Parekh VV, Wu L, Olivares-Villagómez D, Wilson KT, Van Kaer L J Immunol. 2013 Jan 23. PMID: 23345328. Abstract Recent advances in treating multiple sclerosis: efficacy, risks and place in therapy. Jeffery DR Ther Adv Chronic Dis. 2013 Jan; 4(1):45-51. PMID: 23342246. Abstract Oligodendrogenesis from neural stem cells: Perspectives for remyelinating strategies. Grade S, Bernardino L, Malva JO Int J Dev Neurosci. 2013 Jan 20. PMID: 23340483. Abstract Improving adherence to injectable disease-modifying drugs in multiple sclerosis. Bayas A Expert Opin Drug Deliv. 2013 Jan 23. PMID: 23339371. Abstract Effects of natalizumab treatment on the CSF proteome of multiple sclerosis patients. Stoop MP, Singh V, Stingl C, Martin R, Khademi M, Olsson T, Hintzen R, Luider TM J Proteome Res. 2013 Jan 22. PMID: 23339689. Abstract Resistance training and vibration improve muscle strength and functional capacity in female patients with multiple sclerosis. Eftekhari E, Mostahfezian M, Etemadifar M, Zafari A Asian J Sports Med. 2012 Dec; 3(4):279-84. PMID: 23342227. Abstract Therapeutic inhibition of the alternative complement pathway attenuates chronic EAE. Hu X, Holers MV, Thurman JM, Schoeb TR, Ramos TN, Barnum SR Mol Immunol. 2013 Jan 18; 54(3-4):302-308. PMID: 23337717. Abstract [Anti-MOG antibody in different types of immune-mediated optic neuritis]. Kong X-Y, Peng J-T, Liu L-J, Yan R, Zhang X-J Zhonghua Yan Ke Za Zhi. 2012 Dec; 48(12):1069-72. PMID: 23336409. Abstract Renal deterioration in multiple sclerosis patients with neurovesical dysfunction. Fletcher SG, Dillon BE, Gilchrist AS, Haverkorn RM, Yan J, Frohman EM, Lemack GE Mult Scler. 2013 Jan 21. PMID: 23339136. Abstract Lessons Learned From Fatal Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis Treated With Natalizumab. Boster AL, Nicholas JA, Topalli I, Kisanuki YY, Pei W, Morgan-Followell B, Kirsch CF, Racke MK, Pitt D JAMA Neurol. 2013 Jan 21:1-5. PMID: 23338729. Abstract Imatinib-induced amelioration of neurologic deficits in a rare case of simultaneous association of missed multiple sclerosis and chronic myeloblastic leukemia. Siroos B, Harirchian M, Abolfazli R Mult Scler. 2013 Jan 21. PMID: 23339135. Abstract Switching from natalizumab to fingolimod: an observational study. Sempere AP, Martín-Medina P, Berenguer-Ruiz L, Pérez-Carmona N, Sanchez-Perez R, Polache-Vengud J, Feliu-Rey E Acta Neurol Scand. 2013 Jan 22. PMID: 23336398. Abstract Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy. Kluger BM, Krupp LB, Enoka RM Neurology. 2013 Jan 22; 80(4):409-16. PMID: 23339207. Abstract The Persian Version of Community Integration Questionnaire in persons with multiple sclerosis: translation, reliability, validity, and factor analysis. Negahban H, Fattahizadeh P, Ghasemzadeh R, Salehi R, Majdinasab N, Mazaheri M Disabil Rehabil. 2013 Jan 21. PMID: 23330593. Abstract Vitamin A and systemic inflammation as protective factors in multiple sclerosis. Salzer J, Hallmans G, Nyström M, Stenlund H, Wadell G, Sundström P Mult Scler. 2013 Jan 18. PMID: 23334316. Abstract In vitro and in vivo evaluation of a humanized anti-APRIL antibody. Gao Q, Li Q, Xue Z, Wu P, Yang X Curr Mol Med. 2013 Jan 15. PMID: 23331019. Abstract Tumefactive demyelination: an approach to diagnosis and management. Hardy TA, Chataway J J Neurol Neurosurg Psychiatry. 2013 Jan 19. PMID: 23334629. Abstract Dibutyryl Cyclic AMP Inhibits the Progression of Experimental Autoimmune Encephalomyelitis and Potentiates Recruitment of Endogenous Neural Stem Cells. Khezri S, Javan M, Goudarzvand M, Semnanian S, Baharvand H J Mol Neurosci. 2013 Jan 19. PMID: 23335001. Abstract Soluble CD146 in cerebrospinal fluid of active multiple sclerosis. Duan H, Luo Y, Hao H, Feng L, Zhang Y, Lu D, Xing S, Feng J, Yang D, Song L, et al. Neuroscience. 2013 Jan 16. PMID: 23333866. Abstract A 17 year-old girl with a demyelinating disease requiring mechanical ventilation: a case report. Katsenos C, Androulaki D, Lyra S, Tsoutsouras T, Mandragos C BMC Res Notes. 2013 Jan 18; 6(1):22. PMID: 23331922. Abstract Vitamin D-binding Protein in Cerebrospinal Fluid is Associated with Multiple Sclerosis Progression. Yang M, Qin Z, Zhu Y, Li Y, Qin Y, Jing Y, Liu S Mol Neurobiol. 2013 Jan 22. Epub 2013 Jan 22. PMID: 23339019. Abstract MicroRNA dysregulation in multiple sclerosis. de Jr O F, Moore CS, Kennedy TE, Antel JP, Bar-Or A, Dhaunchak AS Front Genet. 2012; 3:311. Epub 2013 Jan 22. PMID: 23346094. Abstract Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment. Huynh JL, Casaccia P Lancet Neurol. 2013 Feb; 12(2):195-206. PMID: 23332363. Abstract Hyaluronan oligosaccharides perturb lymphocyte slow rolling on brain vascular endothelial cells: Implications for inflammatory demyelinating disease. Winkler CW, Foster SC, Itakura A, Matsumoto SG, Asari A, McCarty O J, Sherman LS Matrix Biol. 2013 Jan 16. PMID: 23333375. Abstract Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS. Methner A, Zipp F Nat Rev Neurol. 2013 Feb; 9(2):72-3. Epub 2013 Jan 22. PMID: 23338282. Abstract Structural equation modeling of factors contributing to quality of life in Japanese patients with multiple sclerosis. Kikuchi H, Mifune N, Niino M, Kira J-I, Kohriyama T, Ota K, Tanaka M, Ochi H, Nakane S, Kikuchi S BMC Neurol. 2013; 13:10. Epub 2013 Jan 22. PMID: 23339479. Abstract Removal of access to alemtuzumab for patients with aggressive multiple sclerosis. Thompson AJ, Giovannoni G BMJ. 2013; 346:f275. PMID: 23335474. Abstract Use of imaging to study leukocyte trafficking in the central nervous system. Zenaro E, Rossi B, Angiari S, Constantin G Immunol Cell Biol. 2013 Jan 22. Epub 2013 Jan 22. PMID: 23337699. Abstract Utilization of physical rehabilitation among people with multiple sclerosis. Milivojević I, Adamec I, Habek M Ir J Med Sci. 2013 Jan 22. Epub 2013 Jan 22. PMID: 23338542. Abstract Selective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis. Hendrickx DAE, Koning N, Schuurman KG, van Strien ME, van Eden CG, Hamann J, Huitinga I J Neuropathol Exp Neurol. 2013 Feb; 72(2):106-18. PMID: 23334594. Abstract Short-term safety of pulse steroid therapy in multiple sclerosis relapses. Shaygannejad V, Ashtari F, Alinaghian M, Norouzi R, Salari M, Fatehi F Clin Neuropharmacol. 2013 Jan; 36(1):1-3. PMID: 23334067. Abstract Snake bite-induced leucoencephalopathy. Chaudhary S C, Sawlani K K, Malhotra H S, Singh J BMJ Case Rep. 2013; 2013. PMID: 23334491. Abstract Expression of vitamin d receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue. Smolders J, Schuurman KG, van Strien ME, Melief J, Hendrickx D, Hol EM, van Eden C, Luchetti S, Huitinga I J Neuropathol Exp Neurol. 2013 Feb; 72(2):91-105. PMID: 23334593. Abstract Live cell imaging techniques to study T cell trafficking across the blood-brain barrier in vitro and in vivo. Coisne C, Lyck R, Engelhardt B Fluids Barriers CNS. 2013; 10(1):7. Epub 2013 Jan 21. PMID: 23336847. Abstract Cerebrospinal Fluid High-Mobility Group Box Protein 1 in Neuromyelitis Optica and Multiple Sclerosis. Wang H, Wang K, Wang C, Xu F, Zhong X, Qiu W, Hu X Neuroimmunomodulation. 2013 Jan 10; 20(2):113-118. Epub 2013 Jan 10. PMID: 23328212. Abstract Quantitative MRI Analysis of the Brain after Twenty-Two Years of Neuromyelitis Optica Indicates Focal Tissue Damage. Aradi M, Koszegi E, Orsi G, Perlaki G, Trauninger A, Toth A, Schwarcz A, Illes Z Eur Neurol. 2013 Jan 10; 69(4):221-225. Epub 2013 Jan 10. PMID: 23344153. Abstract Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels. Kim S-H, Kim W, Huh S-Y, Lee K Y, Jung I J, Kim H J J Clin Neurol. 2013 Jan; 9(1):36-42. Epub 2013 Jan 03. PMID: 23346159. Abstract Inflammatory demyelinating central nervous system diseases in childhood: clinical and paraclinical profiles in 133 patients. Kaya D, Idiman E, Ozakbaş S Autoimmune Dis. 2012; 2012:957802. Epub 2012 Dec 30. PMID: 23346388. Abstract Theranostic implications of nanotechnology in multiple sclerosis: a future perspective. Singh A V, Khare M, Gade WN, Zamboni P Autoimmune Dis. 2012; 2012:160830. Epub 2012 Dec 30. PMID: 23346386. Abstract Anti-integrin therapy for multiple sclerosis. Kawamoto E, Nakahashi S, Okamoto T, Imai H, Shimaoka M Autoimmune Dis. 2012; 2012:357101. Epub 2012 Dec 17. PMID: 23346387. Abstract
Editors' Pick Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship? Borisow N, Meyer T, Paul F BMJ Case Rep. 2013; 2013. Epub 1969 Dec 31. PMID: 23349176. Abstract
Editors' Pick Development of a Standardized MRI Scoring Tool for CNS Demyelination In Children. Verhey LH, Branson HM, Laughlin S, Shroff MM, Benseler SM, Feldman BM, Streiner DL, Sled JG, Banwell B AJNR Am J Neuroradiol. 2013 Jan 24. Epub 1969 Dec 31. PMID: 23348761. Abstract
Editors' Pick Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis - Association and Prediction. Løken-Amsrud KI, Myhr K-M, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, et al. PLoS One. 2013; 8(1):e54417. Epub 2013 Jan 22. PMID: 23349882. Abstract
Exposure to anaesthetic agents does not affect multiple sclerosis risk. Hedström A, Hillert J, Olsson T, Alfredsson L Eur J Neurol. 2013 Jan 24. PMID: 23347426. Abstract
Exercise barriers and preferences among women and men with multiple sclerosis. Asano M, Duquette P, Andersen R, Lapierre Y, Mayo NE Disabil Rehabil. 2013 Mar; 35(5):353-61. PMID: 23347461. Abstract
MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentary. Selchen D, Bhan V, Blevins G, Devonshire V, Duquette P, Grand'Maison F, Kremenchutzky M, Lapierre Y, Li D, von Riedemann S J, et al. Neurology. 2012 Dec 4; 79(23 Suppl 2):S1-15. PMID: 23212280. Abstract
Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis. Baumstarck K, Pelletier J, Butzkueven H, Fernández O, Flachenecker P, Idiman E, Stecchi S, Boucekine M, Auquier P, for the MusiQoL study group Eur J Neurol. 2013 Jan 24. PMID: 23347258. Abstract
Quality of life in patients with multiple sclerosis in Republic of Srpska. Tadić D, Dajić V Med Glas Ljek komore Zenicko-doboj kantona. 2013 Feb; 10(1):113-9. PMID: 23348172. Abstract
Spatial tuning function of pattern visual evoked potentials in multiple sclerosis patients without optic neuritis history. Taş A, Gundogan F C, Akgun H, Erdem U, Sobaci G Med Glas Ljek komore Zenicko-doboj kantona. 2013 Feb; 10(1):99-105. PMID: 23348170. Abstract
Functional Homotopic Changes in Multiple Sclerosis with Resting-State Functional MR Imaging. Zhou Y, Milham M, Zuo X-N, Kelly C, Jaggi H, Herbert J, Grossman RI, Ge Y AJNR Am J Neuroradiol. 2013 Jan 24. PMID: 23348760. Abstract
Visualizing iron in multiple sclerosis. Bagnato F, Hametner S, Welch E B Magn Reson Imaging. 2013 Jan 21. PMID: 23347601. Abstract
The therapeutic value of yoga in neurological disorders. Mishra SK, Singh P, Bunch SJ, Zhang R Ann Indian Acad Neurol. 2012 Oct; 15(4):247-54. PMID: 23349587. Abstract
A cluster randomised controlled trial on the efficacy of client-centred occupational therapy in multiple sclerosis: good process, poor outcome. Eyssen ICJM, Steultjens MPM, de Groot V, Steultjens EMJ, Knol DL, Polman CH, Dekker J Disabil Rehabil. 2013 Jan 24. PMID: 23343363. Abstract
Documenting outdoor activity and travel behaviour in persons with neurological conditions using travel diaries and GPS tracking technology: a pilot study in multiple sclerosis. Neven A, Janssens D, Alders G, Wets G, Van Wijmeersch B, Feys P Disabil Rehabil. 2013 Jan 24. PMID: 23343357. Abstract
Your client has multiple sclerosis: understanding the challenge. Orthop Nurs. 2013 Jan; 32(1):51-2. PMID: 23344492. Abstract
Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology. Comi G, Battaglia M A, Bertolotto A, Del Sette M, Ghezzi A, Malferrari G, Salvetti M, Sormani M P, Tesio L, Stolz E, et al. Neurol Sci. 2013 Jan 24. PMID: 23344741. Abstract
Oligodendrocyte N-Methyl-D-aspartate Receptor Signaling: Insights into Its Functions. Cao N, Yao Z-X Mol Neurobiol. 2013 Jan 24. PMID: 23345133. Abstract
Your client has multiple sclerosis: understanding the challenge. Turkoski B Orthop Nurs. 2013 Jan; 32(1):45-50. PMID: 23344490. Abstract
Female Gender and Reproductive Factors Affecting Risk, Relapses and Progression in Multiple Sclerosis. D'hooghe M, D'Hooghe T, De Keyser J Gynecol Obstet Invest. 2013 Jan 18. PMID: 23343711. Abstract
Eriocalyxin B ameliorates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells. Lu Y, Chen B, Song J-H, Zhen T, Wang B-Y, Li X, Liu P, Yang X, Zhang Q-L, Xi X-D, et al. Proc Natl Acad Sci U S A. 2013 Jan 23. PMID: 23345445. Abstract
Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation. Lossius A, Johansen JN, Torkildsen Ø, Vartdal F, Holmøy T Viruses. 2012 Dec; 4(12):3701-30. PMID: 23342374. Abstract
Activated Invariant NKT Cells Control Central Nervous System Autoimmunity in a Mechanism That Involves Myeloid-Derived Suppressor Cells. Parekh VV, Wu L, Olivares-Villagómez D, Wilson KT, Van Kaer L J Immunol. 2013 Jan 23. PMID: 23345328. Abstract
Recent advances in treating multiple sclerosis: efficacy, risks and place in therapy. Jeffery DR Ther Adv Chronic Dis. 2013 Jan; 4(1):45-51. PMID: 23342246. Abstract
Oligodendrogenesis from neural stem cells: Perspectives for remyelinating strategies. Grade S, Bernardino L, Malva JO Int J Dev Neurosci. 2013 Jan 20. PMID: 23340483. Abstract
Improving adherence to injectable disease-modifying drugs in multiple sclerosis. Bayas A Expert Opin Drug Deliv. 2013 Jan 23. PMID: 23339371. Abstract
Effects of natalizumab treatment on the CSF proteome of multiple sclerosis patients. Stoop MP, Singh V, Stingl C, Martin R, Khademi M, Olsson T, Hintzen R, Luider TM J Proteome Res. 2013 Jan 22. PMID: 23339689. Abstract
Resistance training and vibration improve muscle strength and functional capacity in female patients with multiple sclerosis. Eftekhari E, Mostahfezian M, Etemadifar M, Zafari A Asian J Sports Med. 2012 Dec; 3(4):279-84. PMID: 23342227. Abstract
Therapeutic inhibition of the alternative complement pathway attenuates chronic EAE. Hu X, Holers MV, Thurman JM, Schoeb TR, Ramos TN, Barnum SR Mol Immunol. 2013 Jan 18; 54(3-4):302-308. PMID: 23337717. Abstract
[Anti-MOG antibody in different types of immune-mediated optic neuritis]. Kong X-Y, Peng J-T, Liu L-J, Yan R, Zhang X-J Zhonghua Yan Ke Za Zhi. 2012 Dec; 48(12):1069-72. PMID: 23336409. Abstract
Renal deterioration in multiple sclerosis patients with neurovesical dysfunction. Fletcher SG, Dillon BE, Gilchrist AS, Haverkorn RM, Yan J, Frohman EM, Lemack GE Mult Scler. 2013 Jan 21. PMID: 23339136. Abstract
Lessons Learned From Fatal Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis Treated With Natalizumab. Boster AL, Nicholas JA, Topalli I, Kisanuki YY, Pei W, Morgan-Followell B, Kirsch CF, Racke MK, Pitt D JAMA Neurol. 2013 Jan 21:1-5. PMID: 23338729. Abstract
Imatinib-induced amelioration of neurologic deficits in a rare case of simultaneous association of missed multiple sclerosis and chronic myeloblastic leukemia. Siroos B, Harirchian M, Abolfazli R Mult Scler. 2013 Jan 21. PMID: 23339135. Abstract
Switching from natalizumab to fingolimod: an observational study. Sempere AP, Martín-Medina P, Berenguer-Ruiz L, Pérez-Carmona N, Sanchez-Perez R, Polache-Vengud J, Feliu-Rey E Acta Neurol Scand. 2013 Jan 22. PMID: 23336398. Abstract
Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy. Kluger BM, Krupp LB, Enoka RM Neurology. 2013 Jan 22; 80(4):409-16. PMID: 23339207. Abstract
The Persian Version of Community Integration Questionnaire in persons with multiple sclerosis: translation, reliability, validity, and factor analysis. Negahban H, Fattahizadeh P, Ghasemzadeh R, Salehi R, Majdinasab N, Mazaheri M Disabil Rehabil. 2013 Jan 21. PMID: 23330593. Abstract
Vitamin A and systemic inflammation as protective factors in multiple sclerosis. Salzer J, Hallmans G, Nyström M, Stenlund H, Wadell G, Sundström P Mult Scler. 2013 Jan 18. PMID: 23334316. Abstract
In vitro and in vivo evaluation of a humanized anti-APRIL antibody. Gao Q, Li Q, Xue Z, Wu P, Yang X Curr Mol Med. 2013 Jan 15. PMID: 23331019. Abstract
Tumefactive demyelination: an approach to diagnosis and management. Hardy TA, Chataway J J Neurol Neurosurg Psychiatry. 2013 Jan 19. PMID: 23334629. Abstract
Dibutyryl Cyclic AMP Inhibits the Progression of Experimental Autoimmune Encephalomyelitis and Potentiates Recruitment of Endogenous Neural Stem Cells. Khezri S, Javan M, Goudarzvand M, Semnanian S, Baharvand H J Mol Neurosci. 2013 Jan 19. PMID: 23335001. Abstract
Soluble CD146 in cerebrospinal fluid of active multiple sclerosis. Duan H, Luo Y, Hao H, Feng L, Zhang Y, Lu D, Xing S, Feng J, Yang D, Song L, et al. Neuroscience. 2013 Jan 16. PMID: 23333866. Abstract
A 17 year-old girl with a demyelinating disease requiring mechanical ventilation: a case report. Katsenos C, Androulaki D, Lyra S, Tsoutsouras T, Mandragos C BMC Res Notes. 2013 Jan 18; 6(1):22. PMID: 23331922. Abstract
Vitamin D-binding Protein in Cerebrospinal Fluid is Associated with Multiple Sclerosis Progression. Yang M, Qin Z, Zhu Y, Li Y, Qin Y, Jing Y, Liu S Mol Neurobiol. 2013 Jan 22. Epub 2013 Jan 22. PMID: 23339019. Abstract
MicroRNA dysregulation in multiple sclerosis. de Jr O F, Moore CS, Kennedy TE, Antel JP, Bar-Or A, Dhaunchak AS Front Genet. 2012; 3:311. Epub 2013 Jan 22. PMID: 23346094. Abstract
Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment. Huynh JL, Casaccia P Lancet Neurol. 2013 Feb; 12(2):195-206. PMID: 23332363. Abstract
Hyaluronan oligosaccharides perturb lymphocyte slow rolling on brain vascular endothelial cells: Implications for inflammatory demyelinating disease. Winkler CW, Foster SC, Itakura A, Matsumoto SG, Asari A, McCarty O J, Sherman LS Matrix Biol. 2013 Jan 16. PMID: 23333375. Abstract
Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS. Methner A, Zipp F Nat Rev Neurol. 2013 Feb; 9(2):72-3. Epub 2013 Jan 22. PMID: 23338282. Abstract
Structural equation modeling of factors contributing to quality of life in Japanese patients with multiple sclerosis. Kikuchi H, Mifune N, Niino M, Kira J-I, Kohriyama T, Ota K, Tanaka M, Ochi H, Nakane S, Kikuchi S BMC Neurol. 2013; 13:10. Epub 2013 Jan 22. PMID: 23339479. Abstract
Removal of access to alemtuzumab for patients with aggressive multiple sclerosis. Thompson AJ, Giovannoni G BMJ. 2013; 346:f275. PMID: 23335474. Abstract
Use of imaging to study leukocyte trafficking in the central nervous system. Zenaro E, Rossi B, Angiari S, Constantin G Immunol Cell Biol. 2013 Jan 22. Epub 2013 Jan 22. PMID: 23337699. Abstract
Utilization of physical rehabilitation among people with multiple sclerosis. Milivojević I, Adamec I, Habek M Ir J Med Sci. 2013 Jan 22. Epub 2013 Jan 22. PMID: 23338542. Abstract
Selective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis. Hendrickx DAE, Koning N, Schuurman KG, van Strien ME, van Eden CG, Hamann J, Huitinga I J Neuropathol Exp Neurol. 2013 Feb; 72(2):106-18. PMID: 23334594. Abstract
Short-term safety of pulse steroid therapy in multiple sclerosis relapses. Shaygannejad V, Ashtari F, Alinaghian M, Norouzi R, Salari M, Fatehi F Clin Neuropharmacol. 2013 Jan; 36(1):1-3. PMID: 23334067. Abstract
Snake bite-induced leucoencephalopathy. Chaudhary S C, Sawlani K K, Malhotra H S, Singh J BMJ Case Rep. 2013; 2013. PMID: 23334491. Abstract
Expression of vitamin d receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue. Smolders J, Schuurman KG, van Strien ME, Melief J, Hendrickx D, Hol EM, van Eden C, Luchetti S, Huitinga I J Neuropathol Exp Neurol. 2013 Feb; 72(2):91-105. PMID: 23334593. Abstract
Live cell imaging techniques to study T cell trafficking across the blood-brain barrier in vitro and in vivo. Coisne C, Lyck R, Engelhardt B Fluids Barriers CNS. 2013; 10(1):7. Epub 2013 Jan 21. PMID: 23336847. Abstract
Cerebrospinal Fluid High-Mobility Group Box Protein 1 in Neuromyelitis Optica and Multiple Sclerosis. Wang H, Wang K, Wang C, Xu F, Zhong X, Qiu W, Hu X Neuroimmunomodulation. 2013 Jan 10; 20(2):113-118. Epub 2013 Jan 10. PMID: 23328212. Abstract
Quantitative MRI Analysis of the Brain after Twenty-Two Years of Neuromyelitis Optica Indicates Focal Tissue Damage. Aradi M, Koszegi E, Orsi G, Perlaki G, Trauninger A, Toth A, Schwarcz A, Illes Z Eur Neurol. 2013 Jan 10; 69(4):221-225. Epub 2013 Jan 10. PMID: 23344153. Abstract
Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels. Kim S-H, Kim W, Huh S-Y, Lee K Y, Jung I J, Kim H J J Clin Neurol. 2013 Jan; 9(1):36-42. Epub 2013 Jan 03. PMID: 23346159. Abstract
Inflammatory demyelinating central nervous system diseases in childhood: clinical and paraclinical profiles in 133 patients. Kaya D, Idiman E, Ozakbaş S Autoimmune Dis. 2012; 2012:957802. Epub 2012 Dec 30. PMID: 23346388. Abstract
Theranostic implications of nanotechnology in multiple sclerosis: a future perspective. Singh A V, Khare M, Gade WN, Zamboni P Autoimmune Dis. 2012; 2012:160830. Epub 2012 Dec 30. PMID: 23346386. Abstract
Anti-integrin therapy for multiple sclerosis. Kawamoto E, Nakahashi S, Okamoto T, Imai H, Shimaoka M Autoimmune Dis. 2012; 2012:357101. Epub 2012 Dec 17. PMID: 23346387. Abstract